The expression of four out of these ten partners in ccRCC, NPHP3, DVL1, DVL3, and ANKS6 was found to be significantly related to the overall and disease-specific survival (Figure 5). This evidence concerns the gene ANKS6 and nonpapillary renal cell carcinoma.